Research output per year
Research output per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Related documents
Education/Academic qualification
博士（薬学）, 帝京大学アジア国際感染症制御研究所・兼担教授
修士（薬学）, 日本大学生物科学資源学部獣医学科准教授
External positions
准教授, Faculty of Pharmaceutical Sciences, Teikyo University
Apr 2020 → …
副薬剤部長, 帝京大学医学部附属病院
Apr 2019 → …
講師, Faculty of Pharmaceutical Sciences, Teikyo University
Jan 2018 → Mar 2020
助教, Faculty of Pharmaceutical Sciences, Teikyo University
Oct 2016 → Dec 2017
助手, Faculty of Pharmaceutical Sciences, Teikyo University
Apr 2008 → Sep 2016
Fukushima Medical University
Apr 2003 → …
Tokyo Medical and Dental University
Apr 2001 → …
Chiba University
Oct 1997 → …
研修生, Chiba University
Apr 1997 → Sep 1997
Research Fields
- Clinical pharmacy
- Pharmacology
Fingerprint
Dive into the research topics where TAMAKI WATANABE is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Pseudogenization of the Slc23a4 gene is necessary for the survival of Xdh-deficient mice
Terada, K., Watanabe, T., Yasuno, N., Ohtsubo, T., Shibata, S., Ichida, K. & Hosoyamada, M., Dec 2025, In: Scientific Reports. 15, 1, 3250.Research output: Contribution to journal › Article › peer-review
Open Access -
Vancomycin dosing design method considering risk factors for nephrotoxicity
Matsuki, Y., Kozima, Y., Yanagi, M., Sako, K. I., Watanabe, T., Yasuno, N. & Watanabe, S., Dec 2025, In: Journal of Pharmaceutical Health Care and Sciences. 11, 1, 14.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
e-PROによる有害事象モニタリングが乳がん術後薬物療法患者の薬剤性肺炎の早期発見に繋がった一例
瑞生川島, 雄太徳留, 優輝武井, 敦文野本, 優子三宅, 有彩義那, 雅勇土屋, 義治光永, 多真紀渡部 & 伸浩安野, May 2024, In: 日本臨床腫瘍薬学会雑誌. 36, p. 340Research output: Contribution to journal › Conference article › peer-review
-
がん化学療法患者に対するePRO導入における薬剤師業務及び患者対応の質的検討
優輝武井, 雄太徳留, 敦文野本, 瑞生川島, 優子三宅, 有彩義那, 義治光永, 篤司久保田, 多真紀渡部 & 伸浩安野, May 2024, In: 日本臨床腫瘍薬学会雑誌. 36, p. 424Research output: Contribution to journal › Conference article › peer-review
-
メチシリン感性S.aureus(MSSA)による持続菌血症・化膿性血栓性静脈炎に対してASTによる治療支援を行った1例
匠足立, 直久松永, 智湖竹澤, 孝俊山元, 多真紀渡部, 潤平佐々木, あむろ近藤, 隆司千葉, 圭一北國, 俊輔小林, 篤司久保田, 義治光永 & 伸浩安野, Jan 2024, In: Japanese Journal of Chemotherapy. 72, 1, p. 103Research output: Contribution to journal › Conference article › peer-review